identifier	patientIdentifier	gene	rnaExpression	imputedGeneExpression	dnaVariantAlleleFrequency	rnaVariantAlleleFrequency	mutation.position	mutation.wildTypeXmer	mutation.mutatedXmer
uoMiualBhQrqtP0c6UXKew==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	25.33	0.0	0.106	0.963	14	VLVTHTDAVKISDFGTSKELSDKSTKM	VLVTHTDAVKISDWGTSKELSDKSTKM
/SiJ4V3oTVH0ryP8AhTLPQ==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	77.99	0.0	0.379	0.119	14	YQCQSGTGHCLPVTLRGSNYTSKYLGM	YQCQSGTGHCLPVDLRGSNYTSKYLGM
1VZdon2phzmakT00EwBTFw==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	85.95	0.0	0.662	0.623	14	RKGLQCAQQGRFLHRLHQGSAEAGAPC	RKGLQCAQQGRFLRRLHQGSAEAGAPC
mDB9sS+vR4/smtr6k0NPOA==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	88.35	0.0	0.618	0.703	14	GARGIPGIKGTKGSPGNIKDQPRPAFS	GARGIPGIKGTKGVPGNIKDQPRPAFS
zLJ2kuwvtna6is+hpzapdg==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	34.52	0.0	0.961	0.925	14	LSWVFLVAILKGVQCEVQLVESGGGLV	LSWVFLVAILKGVNCEVQLVESGGGLV
spowyQQ0X3+SB5aka0KmQQ==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	49.7	0.0	0.537	0.11	14	PKGRTFGDVLQPAKPEYRVGEVAEVIF	PKGRTFGDVLQPAFPEYRVGEVAEVIF
CBorlMYvQv/cp76ZDPs1gg==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	18.52	0.0	0.463	0.663	14	SSFSETVAFFLGALSVMPAVHTFSLFA	SSFSETVAFFLGACSVMPAVHTFSLFA
NuvG9E+aot67qxkD9lhaxQ==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	18.47	0.0	0.906	0.731	14	INLELYASYVYLSMSYYFDRDDVALKN	INLELYASYVYLSCSYYFDRDDVALKN
v+EuLlY25/FgDUlNvsUDkw==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	20.32	0.0	0.222	0.881	14	EKALSLHQIPDAGAREGVSVQYVPHQG	EKALSLHQIPDAGKREGVSVQYVPHQG
SrJZHAGVuZ65UqNDPy6ZJQ==	d7154b30-3009-4918-96bd-eb9d28b57b4a	BRCA2	88.65	0.0	0.304	0.557	14	RRQEARRPEEGGARAALSWPRLLSRFR	RRQEARRPEEGGALAALSWPRLLSRFR
I3ZHH8pySpPjlQPdW8VxJg==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	78.34	0.0	0.816	0.483	14	KLKKDLCYHNSDSPEYQDSSFSLIVAF	KLKKDLCYHNSDSAEYQDSSFSLIVAF
dLREBYUqTZyW8n5Ny85HBg==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	43.74	0.0	0.512	0.107	14	IQTLMQKMIQQIKYNVKSRLSDVSSGE	IQTLMQKMIQQIKQNVKSRLSDVSSGE
8hmhiAxKjATYQpRYQWlblQ==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	41.91	0.0	0.186	0.717	14	DVSMFLLLPDEIADVSTGLELLESEIT	DVSMFLLLPDEIACVSTGLELLESEIT
Jn6LvHegYL27u/jDPxfY3g==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	73.9	0.0	0.752	0.244	14	VVFKGEKRRGHTGEIGLDDVSLKKGHC	VVFKGEKRRGHTGRIGLDDVSLKKGHC
vx8PTuTxzbwZY6bY7RPSLw==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	72.95	0.0	0.193	0.105	14	VRKAHFIQHQRVHTGEKPFQCNECGKS	VRKAHFIQHQRVHGGEKPFQCNECGKS
Urx1gLRao7Gt3alX88bjxg==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	22.21	0.0	0.494	0.787	14	HLWAAIEIIRNQKQIANIDRITKYMSR	HLWAAIEIIRNQKFIANIDRITKYMSR
59xdsuqoBi3RVQHqLPoEhQ==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	44.76	0.0	0.989	0.951	14	CNGQIERGCEVALMKADLQGPSTTCQE	CNGQIERGCEVALEKADLQGPSTTCQE
mSxsrYe+1v4yeOTfVHLG5w==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	49.19	0.0	0.614	0.681	14	MTYWRLENIAKTEPPKIFRVKPVLGIK	MTYWRLENIAKTEDPKIFRVKPVLGIK
bTCp9TdlorKOywX4X73DYw==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	51.01	0.0	0.628	0.667	14	YNQYTFSEHSVLDIVNTPNIVVPPEVV	YNQYTFSEHSVLDFVNTPNIVVPPEVV
BdGWt7h0Suu0e8ggPFNoiQ==	1d95b28d-099c-4e11-9f99-da69b9d5debe	BRCA2	27.49	0.0	0.102	0.755	14	DREKTPELNLLLTATDGGKPELTGTVR	DREKTPELNLLLTQTDGGKPELTGTVR
qR7SY62BDq6gdz7Iqubt3w==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	84.77	0.0	0.104	0.202	14	LGSADVATINSTGITLSLSSEESESSK	LGSADVATINSTGPTLSLSSEESESSK
ISEm1OHHLAf1ZuW1aqHDpw==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	18.1	0.0	0.565	0.402	14	MSELEKAMVALIDVFHQYSGREGDKHK	MSELEKAMVALIDCFHQYSGREGDKHK
2aS4p4NKvwNKe2ZeoFZKfw==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	49.59	0.0	0.78	0.754	14	LDCNFDIKVLNAQRAGYKAAIVHNVDS	LDCNFDIKVLNAQFAGYKAAIVHNVDS
AWADIaBBFhm05ygvkr0osg==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	22.66	0.0	0.795	0.184	14	ECMQDFNTMFTNCYIYNKPTDDIVLMA	ECMQDFNTMFTNCGIYNKPTDDIVLMA
L57ya7/OpRmmzDnfRUkLhw==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	33.9	0.0	0.145	0.652	14	EEIEGFPSPPDFILMADCIYYEESLEP	EEIEGFPSPPDFITMADCIYYEESLEP
PdA5jb0JCYM6DaBo4bEQkA==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	93.04	0.0	0.78	0.113	14	PYSVLLKDLEMRNLRELEDLIIEAVYT	PYSVLLKDLEMRNQRELEDLIIEAVYT
3U63mpjCqRarxlpxwnsoJA==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	98.65	0.0	0.1	0.605	14	QALALESRGMGEMQKRVQVSPLGHKRA	QALALESRGMGEMDKRVQVSPLGHKRA
E+G90A0+An7UoYoTnrIjWQ==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	50.25	0.0	0.302	0.913	14	VRQPGSSSSSAPGQPSTGVARPTVSSG	VRQPGSSSSSAPGKPSTGVARPTVSSG
xdWb5xZw1LAWOrWwTxSAFg==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	31.75	0.0	0.234	0.217	14	KRSLCYCESCRKLRGDEAHRRRGEPPR	KRSLCYCESCRKLQGDEAHRRRGEPPR
hu7Lns/aFe8ftztJRDeZLw==	ec4957f3-cca4-41e2-b207-330f4d72135e	BRCA2	61.62	0.0	0.888	0.461	14	PKSLPKQASDTGSNDAHNKKAVSRSAE	PKSLPKQASDTGSADAHNKKAVSRSAE
9WwPRTKuKyNA9PZf39rnww==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	83.07	0.0	0.593	0.816	14	ELGAPGTVALVAARAERGARLPSPGSC	ELGAPGTVALVAAWAERGARLPSPGSC
3V+gsAi2xYgYH2ueb6RLsQ==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	54.82	0.0	0.718	0.384	14	YVQHVPIPKSTGDSLRLEDGQAVQLED	YVQHVPIPKSTGDFLRLEDGQAVQLED
SA3i1kpfqd/e8yJRsarrsw==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	26.38	0.0	0.296	0.546	14	NWTGLYTLLSGVNRHSTAIGRVWLSVI	NWTGLYTLLSGVNKHSTAIGRVWLSVI
E+nKsYknWuemn/DcCNIpKQ==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	31.6	0.0	0.931	0.352	14	EGQDRITRSSGQACRVSPFISTIAIGT	EGQDRITRSSGQAGRVSPFISTIAIGT
D/n3azvL07lxi3O2REU8Ew==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	32.43	0.0	0.418	0.933	14	DFKSQKNFIINMTCRFCWQLPETDYEC	DFKSQKNFIINMTIRFCWQLPETDYEC
ZFXGglpqRUpge3qORdiNig==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	25.16	0.0	0.402	0.618	14	TIEVLMSSVKEEVASAKEPRSVLDLFC	TIEVLMSSVKEEVQSAKEPRSVLDLFC
/t/hTu9C5IE5bTYeROcEuA==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	84.23	0.0	0.915	0.863	14	GSIMNETDLAGPMVFCLAFGATLLLAG	GSIMNETDLAGPMYFCLAFGATLLLAG
chx3viu5AhYVfQzgQ8gnyQ==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	99.96	0.0	0.387	0.868	14	IMEDKRYKSAAVAASVILRSHPLSPTQ	IMEDKRYKSAAVASSVILRSHPLSPTQ
Me+poJvsH5nRxC23GdMBag==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	34.89	0.0	0.794	0.253	14	QYKCHVILGNLRKNKAGVVIHCNHRIP	QYKCHVILGNLRKYKAGVVIHCNHRIP
hWyAcb8yZwmrhFmqoWVKnQ==	07d7751e-a260-4466-bebf-a9b00842e395	BRCA2	65.57	0.0	0.585	0.869	14	IEIQVVKVTDTTLVPEPPEPGSFHCAL	IEIQVVKVTDTTLAPEPPEPGSFHCAL
6Y/aooU4q2S6k7w2lhoJ9g==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	54.58	0.0	0.999	0.801	14	YCSHCREFIWGVFGKQGYQCQVCTCVV	YCSHCREFIWGVFDKQGYQCQVCTCVV
tpVL6PxaiSGvEZxWGE6O5A==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	73.37	0.0	0.199	0.571	14	RSPGPPQVDGTPTMSLERPPRVPPRAA	RSPGPPQVDGTPTASLERPPRVPPRAA
I8mJcXH6Wr2V3NBOTcB/cQ==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	97.34	0.0	0.528	0.35	14	LLVGITSGMWIWSAKTLHTWQKCSNRL	LLVGITSGMWIWSSKTLHTWQKCSNRL
Zf2I3SE8t4JIz5oNj+6Ggg==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	71.58	0.0	0.607	0.636	14	AQSLVTLWSYNQTCSHFNCAYLGGEKR	AQSLVTLWSYNQTKSHFNCAYLGGEKR
OkyJqowSwPStLrIll5stpQ==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	48.2	0.0	0.952	0.975	14	DELSRTDYEQKRFDQKNQRTKKGQNMT	DELSRTDYEQKRFIQKNQRTKKGQNMT
D3AhI2kcQXNTqpJFDD5x9g==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	12.0	0.0	0.504	0.198	14	LPFLGTILFYLRHRVDFFQQMIDSQNS	LPFLGTILFYLRHTVDFFQQMIDSQNS
e4FUGq/Mp2gSty6o3kashw==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	37.88	0.0	0.509	0.985	14	WMERIHLNVSDPPKKVTTVIQNPMPIR	WMERIHLNVSDPPQKVTTVIQNPMPIR
pZFJ7Ve76NoFTVstVFxpBw==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	70.09	0.0	0.72	0.959	14	RRINLEACSNEMVTFLQGELHVSKLFN	RRINLEACSNEMVEFLQGELHVSKLFN
WxHJH/to/Ht2d6M8pzqk6g==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	12.13	0.0	0.368	0.917	14	LTSALVHLKLHLFIQIFTLAFFPATIW	LTSALVHLKLHLFAQIFTLAFFPATIW
1a8dYITsk5jSt1c2oWFPJQ==	657f15e4-4804-43b7-aa24-05168fb1cd34	BRCA2	63.87	0.0	0.811	0.142	14	CDSLNGLDPSEKEKFSQMLIVNEELQA	CDSLNGLDPSEKEAFSQMLIVNEELQA
uXN6Yz8uK654kUQ6yu7pEw==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	61.83	0.0	0.23	0.601	14	HVQRLSPTMNPALNPTRAPKASRPPKM	HVQRLSPTMNPALCPTRAPKASRPPKM
TrVv15CzfnKJG4LR4zT8fg==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	91.83	0.0	0.325	0.295	14	SADGILCSGKGSCHCGKCICSAEEWYI	SADGILCSGKGSCLCGKCICSAEEWYI
RLF4BeVPvHvUeQWs5XsbTQ==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	62.44	0.0	0.152	0.542	14	VKKMMKFLKTGGETASRYAIKILAICT	VKKMMKFLKTGGESASRYAIKILAICT
KCvsqodG057Iry8uFmU2Fg==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	57.02	0.0	0.297	0.328	14	FSGDFPYQISLWNFSCFQHKEQRRLGN	FSGDFPYQISLWNASCFQHKEQRRLGN
mYvCaygwndXNyOsSmpsZyw==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	39.19	0.0	0.942	0.972	14	LENKELCILRNDWCSVPVEPGDIIHLE	LENKELCILRNDWYSVPVEPGDIIHLE
YoZK7y2eh70Kr83tm1pv8Q==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	91.85	0.0	0.496	0.915	14	HEKAVELLKAAKDSVKLVVRYTPKVLE	HEKAVELLKAAKDFVKLVVRYTPKVLE
AZEvYcpyTLSbfqAj2Zu4uw==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	43.71	0.0	0.672	0.458	14	TGFEAVKEALAGPGQELADRPPIAIFQ	TGFEAVKEALAGPRQELADRPPIAIFQ
5a6/TmqItJTUL4vTjfxArw==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	74.77	0.0	0.192	0.852	14	TSLRGTRPYNQRAAASFFACLVMIAYG	TSLRGTRPYNQRADASFFACLVMIAYG
n57YVgpmaJ8jbTeVg6fzAg==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	73.29	0.0	0.344	0.107	14	EVEGKRALLEIKEREHNQLVKLLELAR	EVEGKRALLEIKEGEHNQLVKLLELAR
59TjIHLbrIHQUOWZ/P009g==	635f80f7-fc66-4542-8fbf-f99646e8c2ee	BRCA2	32.71	0.0	0.155	0.782	14	KQKKHLKDLKLTLQRCKRHASREEAEL	KQKKHLKDLKLTLCRCKRHASREEAEL
hAaa6MpgDCJw/cpUmaanlw==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	76.49	0.0	0.683	0.41	14	KVLKNKFRSKKYFAKHPRLGYLPVQTV	KVLKNKFRSKKYFPKHPRLGYLPVQTV
qqtYCVnO7zIBQe2lSs+n5g==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	92.3	0.0	0.914	0.88	14	IVLSFLLCHPVPYNRHLAEVWRMLSVE	IVLSFLLCHPVPYMRHLAEVWRMLSVE
+72ogLhtTQbRDZtrhSmt2A==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	59.65	0.0	0.895	0.454	14	YQEVSSLCVTKGAEMETQRETEKNASK	YQEVSSLCVTKGAQMETQRETEKNASK
qMI7UaLuSxtIDv8d4zo0Ew==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	91.88	0.0	0.373	0.193	14	SYRIHVLHHGTGKWYELQDLQVTDILP	SYRIHVLHHGTGKVYELQDLQVTDILP
VgZfJQ1DmChdSoGabv+UgQ==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	76.52	0.0	0.352	0.739	14	DEDSPQPVTMEKVVKQSYEFSNSNKNL	DEDSPQPVTMEKVWKQSYEFSNSNKNL
J5XnCeFqWoUaZq7tl0yOWw==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	17.47	0.0	0.582	0.177	14	VGPARRGASSLLGPEGFFLGKMGFREA	VGPARRGASSLLGHEGFFLGKMGFREA
l9wt7J4049uanDnO5kit/Q==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	41.12	0.0	0.614	0.653	14	VYYTLSDVGANQTVLFANPNFLRSIGK	VYYTLSDVGANQTKLFANPNFLRSIGK
mILaeEdVARvPuuNxYUHbSw==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	36.23	0.0	0.668	0.787	14	VYHAEEVQCDGRSFHRCCFLCMVCRKN	VYHAEEVQCDGRSYHRCCFLCMVCRKN
oG1MwD0MEdr1/YYlxZEmbQ==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	60.73	0.0	0.743	0.77	14	LQVIQRAERLDVLEQQRIGRLVERLET	LQVIQRAERLDVLIQQRIGRLVERLET
7mWwi8h1+W9hwyx41e+p1A==	81025877-79f4-4f13-a2ae-3765d7b50c53	BRCA2	37.19	0.0	0.771	0.618	14	VRDYHTFVWSSVPESTTDGSPIHTSVQ	VRDYHTFVWSSVPCSTTDGSPIHTSVQ
PriOOFA9pwOliEoF1VWMVA==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	15.56	0.0	0.328	0.117	14	SDVFPGPSFRSSNPSISDDSYFRKECG	SDVFPGPSFRSSNHSISDDSYFRKECG
1p18ewJb3mAD3HOmM/Ffqw==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	41.17	0.0	0.312	0.43	14	DLDSSLASLVGNLGISGTTTKKGDLQW	DLDSSLASLVGNLFISGTTTKKGDLQW
sYbSLMXLG4yTUG0+zwpX/Q==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	58.81	0.0	0.739	0.989	14	GPEARTLVLRLAQLITQAKHTAKSISD	GPEARTLVLRLAQPITQAKHTAKSISD
HGexYoQ/bAXgvo8bK1G8dA==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	96.07	0.0	0.14	0.397	14	GLLPFALLEFILTCVVSHFGCQATCCR	GLLPFALLEFILTIVVSHFGCQATCCR
NBJFgogbK/6Ge46rBM/WYg==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	42.4	0.0	0.353	0.336	14	GYNVDLLFETLFDLVVPMILQQRAERP	GYNVDLLFETLFDTVVPMILQQRAERP
dUMDdCKypRnaW2LPx4eppg==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	74.12	0.0	0.507	0.201	14	DAPVDNAGFLYKKGGRHAAYHRRWFVL	DAPVDNAGFLYKKHGRHAAYHRRWFVL
1QWRHVubeHaLt0yumudFSQ==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	55.59	0.0	0.3	0.178	14	AEGSKSPWHHIENLDLFFSRVYNLHQK	AEGSKSPWHHIENPDLFFSRVYNLHQK
IVXGwspEPHzvcWW8KO7Jog==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	44.12	0.0	0.295	0.274	14	HSAIKCMRGILYCYMRQADKVQQFKQD	HSAIKCMRGILYCGMRQADKVQQFKQD
rcHsjsANXhK3GdLZfdJGzg==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	94.77	0.0	0.319	0.255	14	FSSHLLADSSSPATNSSHTDAHEILVS	FSSHLLADSSSPAHNSSHTDAHEILVS
rV1M+SZ4k1OSXWLGGZnKnQ==	31a8c150-2fe7-4a43-a06b-e3ceb29bcf35	BRCA2	79.86	0.0	0.524	0.671	14	QQQQQIHLQQKQVVIQQQIAIHHQQQF	QQQQQIHLQQKQVYIQQQIAIHHQQQF
Z/FAdIAHGLPo6qWRVkcbhw==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	41.7	0.0	0.12	0.685	14	HPRYFGPNLLNTVKQKLFTEVEGTCTG	HPRYFGPNLLNTVWQKLFTEVEGTCTG
s6BWQ17HW97b0dJg/XPxIQ==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	31.91	0.0	0.612	0.879	14	LNVLFDSLQERLYTKMNLKPHRSREYL	LNVLFDSLQERLYWKMNLKPHRSREYL
/8C/9YgN5/C9TJvk7WK4rw==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	40.32	0.0	0.315	0.437	14	FPFSAIHQVHNTGDWGEPSITLRPPNE	FPFSAIHQVHNTGAWGEPSITLRPPNE
wFRpqJacXK2asoFSLK85oQ==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	16.08	0.0	0.272	0.398	14	QPGLPYSQVRDMVSKKLELRLEHTKLS	QPGLPYSQVRDMVGKKLELRLEHTKLS
hYQ/OB+5wfZW+FrG+prA4g==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	91.27	0.0	0.441	0.533	14	RENHGQADHSPSMTATHFPRVYGVSLA	RENHGQADHSPSMFATHFPRVYGVSLA
qyX/fX96A05kUtRok0uq1Q==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	53.24	0.0	0.827	0.147	14	EECNVLINLLKECHKNHNILKFFGYCN	EECNVLINLLKECYKNHNILKFFGYCN
vyfpEX57QgYHZeF6j7fcSw==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	84.2	0.0	0.103	0.479	14	YRTYDAYSTFYLNSSGLICRHRLDKVS	YRTYDAYSTFYLNDSGLICRHRLDKVS
xTAl3yUOChSnRnjvIxLJxA==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	79.72	0.0	0.369	0.937	14	FKGCLTLYTGRGGDLQKIGEFCMVYSE	FKGCLTLYTGRGGFLQKIGEFCMVYSE
haVwaHgtqA68idbO60iKOQ==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	17.3	0.0	0.468	0.369	14	CCLWVGELLKGGGGVNWNPGLQPSPEL	CCLWVGELLKGGGRVNWNPGLQPSPEL
j6LOQhqld1nlranil+2WHQ==	0164cd39-4bb0-4056-b2e1-1d9b16ffe6fc	BRCA2	19.41	0.0	0.268	0.193	14	PPPAPPPPPTFALANTEKPTLNKTEQA	PPPAPPPPPTFALWNTEKPTLNKTEQA
yzAK+EhvYQJ+awEy4W5mfw==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	77.51	0.0	0.477	0.984	14	QIVTMIHRTGDVQYRSSVRCYTRQGSA	QIVTMIHRTGDVQIRSSVRCYTRQGSA
IwLW0UWHx5q1w3uKIsd8TA==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	84.25	0.0	0.524	0.209	14	LEQQVKAQTDEILSKDQKIAALEDLVQ	LEQQVKAQTDEILNKDQKIAALEDLVQ
abyCp7J5sOt5jc0qBda/WA==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	73.65	0.0	0.397	0.932	14	CPEPSSVSHQQFQPLHRMQQTNVALLG	CPEPSSVSHQQFQKLHRMQQTNVALLG
tkQa0DRgFGrtwgCpL0SPwQ==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	55.26	0.0	0.753	0.338	14	QEFWEHRMDSNVLFLKYEDMHRDLVTM	QEFWEHRMDSNVLDLKYEDMHRDLVTM
FydHvFL21gYo2WfC+4kNQw==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	90.0	0.0	0.472	0.948	14	TIYLWKWDDKVVISDIDGTITKSDALG	TIYLWKWDDKVVILDIDGTITKSDALG
b34juvVRI7XZgS7dRugX1w==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	26.74	0.0	0.162	0.642	14	EDSPGLKVGPVPVLVMSLLFIASVFML	EDSPGLKVGPVPVAVMSLLFIASVFML
eG0IDs0KeDeL9N/DRKMo+Q==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	80.12	0.0	0.572	0.616	14	PSFEPTKNKELTDEFRELRATVERMGL	PSFEPTKNKELTDSFRELRATVERMGL
+f+GgguzN8vOEDHuaKfgDA==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	27.08	0.0	0.964	0.312	14	PAIVPPSGKQELQPFDRNLKTQAESKA	PAIVPPSGKQELQYFDRNLKTQAESKA
MHQky4nwzQDqcsTsDjThxA==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	80.02	0.0	0.546	0.941	14	KGKIAKNSISLSWQEPDRPNGIILEYE	KGKIAKNSISLSWAEPDRPNGIILEYE
J0EH8KLb2wPh0sXWSFvz0Q==	8200c571-4754-4d38-9239-ccb26f68680d	BRCA2	31.74	0.0	0.876	0.531	14	RGRSVSGGRGRGGPRGGKSSISSVLKD	RGRSVSGGRGRGGHRGGKSSISSVLKD
